Fiorino, T., Sharma, M. R., McKean, M., Brown, J. T., Thomas, J. S., Marron, T. U., O'Brien, S., Guan, X., Bhatia, A., Urwin, K., Sergeeva, O., Fine, J., Spira, A. I. (2026). Eiu-104101: A first-in-human phase 1a/1b study of EVOLVE104, a trispecific CD3×CD2×ULBP2/5/6 T-cell engager, in advanced urothelial and squamous cell carcinomas.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps2682